CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-2-532-7151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-02 | OSTROV GERALD M Director | Grant or award | +8,452 | 38,898 | ||
| 2024-10-02 | Malca Yonatan Director | Grant or award | +8,639 | 39,043 | ||
| 2024-10-02 | LIEBERMAN GERALD M Director | Grant or award | +11,269 | 265,491 | ||
| 2024-10-02 | Ellis Sean Director | Grant or award | +7,466 | 127,627 | ||
| 2024-08-27 | OSTROV GERALD M Director | Grant or award | +20,446 | 30,446 | ||
| 2024-08-27 | Taitel Haya Director | Grant or award | +15,335 | 50,450 | ||
| 2024-08-27 | Ellis Sean Director | Grant or award | +18,061 | 120,161 | ||
| 2024-08-27 | Malca Yonatan Director | Grant or award | +23,172 | 30,404 | ||
| 2024-08-27 | LIEBERMAN GERALD M Director | Grant or award | +27,261 | 254,222 | ||
| 2024-07-31 | Toledano Miranda Jayne Chief Executive Officer | Grant or award | +124,121 | 234,873 | ||
| 2024-07-31 | Toledano Miranda Jayne Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2024-04-19 | Yaacov-Garbeli Dana Chief Financial Officer | Grant or award | +30,151 | 86,731 | ||
| 2024-04-19 | Yaacov-Garbeli Dana Chief Financial Officer | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2024-04-19 | Yaacov-Garbeli Dana Chief Financial Officer | Grant or award | +30,151 | 86,731 | ||
| 2024-04-19 | Yaacov-Garbeli Dana Chief Financial Officer | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2024-04-19 | Galitzer Hillel Chief Operating Officer | Grant or award | +30,151 | 64,257 | ||
| 2024-04-19 | Galitzer Hillel Chief Operating Officer | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2024-01-12 | Taitel Haya Director | Purchase | +9,500 | $0.99 | $9K | 35,115 |
| 2024-01-10 | Taitel Haya Director | Purchase | +7,615 | $0.77 | $6K | 25,615 |
| 2024-01-01 | Taitel Haya Director | Grant or award · Stock Option (right to buy) | +108,333 | 108,333 |
Page 4 of 8 · 147 trades